RETRACTION article

Front. Pharmacol., 27 May 2026

Sec. Pharmacology of Anti-Cancer Drugs

Volume 17 - 2026 | https://doi.org/10.3389/fphar.2026.1880306

Retraction: In vitro anticancer effects of JI017 on two prostate cancer cell lines involve endoplasmic reticulum stress mediated by elevated levels of reactive oxygen species

The journal retracts the 13 May 2021 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. Image duplication concerns were identified in Figure 2B.

The authors and their institution have remained unresponsive to multiple requests for the raw data for this study. Given extant concerns over the validity of the study, the article has been retracted.

This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. The authors have not responded to correspondence regarding this retraction.

Frontiers would like to thank Sholto David for contacting the journal regarding the published article.

Summary

Citation

Frontiers Editorial Office (2026) Retraction: In vitro anticancer effects of JI017 on two prostate cancer cell lines involve endoplasmic reticulum stress mediated by elevated levels of reactive oxygen species. Front. Pharmacol. 17:1880306. doi: 10.3389/fphar.2026.1880306

Received

13 May 2026

Accepted

15 May 2026

Published

27 May 2026

Approved by

Heike Wulff, University of California, Davis, United States

Volume

17 - 2026

Updates

Copyright

*Correspondence: Frontiers Editorial Office,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics